DofetildeActive Ingredient(s): Dofetilide
FDA Approved: * January 22, 2019
Pharm Company: * AUROBINDO PHARMA LTD
Category: Irregular Heartbeat (Arrhythmia)
Dofetilide is a class III antiarrhythmic agent. It is marketed under the trade name Tikosyn by Pfizer, and is available in the United States in capsules containing 125, 250, and 500 µg of dofetilide. It is not available in Europe or Australia. In the United States it is only available by mail order or through specially trained local pharmacies. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Pha... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.